Updated Cochrane review into whether prostate cancer screening reduces deaths (opens in new tab)

Early detection of prostate cancer through screening has long been debated. Multiple trials have investigated prostate cancer screening over the years, commonly using the Prostate-Specific Antigen (PSA) test. This research has highlighted issues around the rates of false positive results, potentially causing anxiety and unnecessary investigations, overdiagnosis, potentially resulting in unnecessary treatments, and false negative results, leading to missed cancers.